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Abstract The acquisition of invasive properties is a crucial 
event during carcinogenesis, determining the clinical outcome. 
The mammary gland at puberty provides an ideal model for 
investigating the induction and control of invasive growth. 
During this growth phase, the mammary epithelium participates 
in a normal, hormonally controlled invasive penetration into the 
stroma. We have applied the differential display method to 
search for genes specifically activated during this developmental 
stage. We have identified and molecularly characterized a novel 
/mbertal mammary g\and specific gene, pmg-l. This gene is 
conserved in mammals and encodes a protein of 19.9 kDa. 
Northern blotting and in situ hybridization revealed that pmg-\ 
expression was exquisitely restricted to the epithelium at early 
puberty. To our knowledge this represents the first isolation of a 
gene specifically associated with the induction of mammary 
epithelial invasiveness at puberty. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The clinical outcome of malignant disease is determined not 
only by the primary tumor itself, but rather by its potential to 
invade and to metastasize. The acquirement of the invasive 
potential is thus a key event during carcinogenesis and a bet-
ter understanding of the molecular events involved will lead to 
new therapeutic possibilities. The mammary gland at puberty 
provides an excellent biological system to investigate the mo-
lecular mechanisms controlling invasive growth. During this 
growth phase, the proliferating epithelium participates in a 
hormonally controlled, limited invasive penetration of the sur-
rounding stroma giving rise to the characteristic ductal tree of 
the mature mammary gland [1]. It is striking that the two 
characteristics of pubertal growth, proliferation and invasion, 
are also the main characteristics of malignant growth. Indeed, 
we have found close parallels in tissue specificity of prolifer-
ation and matrix metalloproteinase expression between nor-
mal pubertal growth and the development of invasive metas-
tasizing mammary tumours [2]. Furthermore, the relevance of 
pubertal development for mammary carcinogenesis is sup-
ported by epidemiological and experimental studies which 
have identified the exposure to estrogen as a main risk factor 
and the developmental processes induced at puberty as pre-
requisites for malignant development [3,4]. 
The molecular mechanism(s) ensuring correct control of the 
pubertal epithelial proliferation, stromal invasion, pattern for-
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mation and finally growth arrest are poorly understood. 
Growth inhibitory effects of TGFJ3-1, -2 and -3 on ductal 
morphogenesis in the pubertal mammary gland have been 
demonstrated [5,6]. In contrast, growth promoting effects of 
EGF and TGFa on the ductal outgrowth at puberty have also 
been observed [7]. The spatially selective expression of E- and 
P-cadherins during branching morphogenesis is thought to be 
involved in tissue integrity and normal growth rate of the 
epithelium [8]. Knock-out mice deficient in the expression of 
either the progesterone receptor or cyclin-Dl exhibit impaired 
branching morphogenesis of the mammary epithelium at pu-
berty [9-11]. 
In an attempt to molecularly characterize genes involved in 
the pubertal growth phase of the mammary epithelium, we 
have applied the differential display cloning method [12] to 
identify genes specifically expressed in the mouse mammary 
gland during this particular developmental window. This ap-
proach has led to the identification of a novel gene, pmg-l, 
whose expression is restricted to the early pubertal growth 
phase of the mammary epithelium thereby implicating pmg-l 
in the hormonally induced initiation and/or promotion of 
mammary epithelial cell growth. 
2. Materials and methods 
2.1. Animals and organoid preparation 
Mammary glands at various stages of development were isolated 
from Swiss Moro female mice (BRL, Fiillinsdorf, CH). Immature 
mammary glands were taken at the age of 2-3 weeks, pubertal mam-
mary glands were collected over the period of 3.5-6 weeks of age and 
mature mammary glands represented the entire estrus cycle [13]. The 
preparation of multicellular organoids comprising myoepithelial and 
epithelial cells was performed essentially as described ([14]. 
2.2. RNA preparation and differential display 
Total RNA was prepared and enriched for poly(A) RNA according 
to Andres et al. [13]. The differential display analysis was performed 
using the GenHunter mRNA Differential Display Kit according to 
the protocol of the manufacturer (Bio/Gene, Bolnhurst, UK). Briefly, 
0.2 ug DNA-free mRNA from immature, pubertal and mature mam-
mary gland organoids was reverse transcribed using the 3'-primer 5'-
AAGCTTTTTTTTTTTTTC-3'. A tenth of the reaction volume was 
amplified by PCR using the random 5'-primers. The amplificates were 
separated on standard sequencing gels, differentially displayed frag-
ments excised from the gel and re-amplified using the same primer set. 
PCR products were cloned into pBluescript and sequenced using the 
dideoxynucleotide chain termination method (Sequenase Version 2.0 
kit, Amersham Switzerland, Zurich, CH). 
2.3. cDNA library construction and screening 
Double-stranded cDNA was made from mRNA of intact pubertal 
mammary glands and cloned into HybriZapII vector using the Hybri-
ZapII cloning kit according to the manufacturer protocol (Stratagene, 
Heidelberg, Germany). Phage plaques were screened with the PCR 
cloned fragment and positive colonies plaque purified. Phage DNA 
was prepared according to standard protocols [15], the insert excised 
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and re-cloned into pBluescript for further analysis. The full-length 
sequence was determined using the Exonuclease III Erase-a-base sys-
tem (Promega, Madison, WI) and Sequenase Version 2.0 (Amersham, 
Switzerland). Sequence comparisons were made using the BLAST 
program [16]. 
2.4. Southern blot analysis 
Genomic DNA was prepared as described [15]. 10 ug of BamHl- or 
ffiwdlll-digested DNA was electrophoresed in a 1% agarose gel and 
blotted onto cellulose nitrate (Schleicher and Schuell, Dassel, Ger-
many). Filters were prehybridized and hybridized with the full-length 
pmg-l cDNA labeled with [32P]dCTP by random priming (Boeh-
ringer-Mannheim, Rotkreuz, CH) at 25°C in 50% formamide, 
4XSSC, 5 X Denhardt's, 0.2% SDS 0.1% tetra-Na-diphosphate and 
100 ng/ml denatured salmon sperm DNA. Filters were washed to a 
final stringency of 2XSSC, 0.5% SDS at 30°C and exposed to X-ray 
film (Kodak, Lausanne, CH). 
2.5. Northern blot analysis and in situ hybridization 
Poly(A)-enriched (5 |xg) or 10 ug of total RNA were separated on 
1% agarose gels as described [17] and blotted onto cellulose nitrate. 
The filters were hybridized to the 32P-labeled full-length pmg-l cDNA 
(hybridization solution as above) at 42°C, washed to a final stringency 
of 0.25 XSSC, 0.2% SDS at 65°C and exposed to X-ray film. In situ 
hybridization of 5-um-thick paraformaldehyde-fixed paraffin sections 
of pubertal mammary glands was performed using the RNA Colour 
Kit according to the manufacturers instructions (Amersham Interna-
tional). The anti-sense probe and the sense control was synthesized by 
in vitro transcription of the pmg-l cDNA using T3 or T7 RNA po-
lymerase. 
3. Results and discussion 
The differential display method comparing RNA isolated 
from immature, pubertal and mature mammary organoids 
led to the identification of a cDNA fragment present in the 
pubertal RNA only. This fragment was cloned and used as a 
probe to screen a cDNA library derived from pubertal mam-
mary glands. A full-length cDNA clone with a 858 bp insert 
was isolated for further characterization. Sequence determina-
tion and comparison with the GenBank database revealed 
1 GCACGAGATTCTCCTTATCCCATCCTCAAACTCCTAGCTCCTCTCAACATGTCCTGCAAC 60 
61 AGCTCCTCTX-GAACTTTCTCCCAGTCCTTTGGGGGCGAACTGCAGTATCCGATCTCTTCA 12 0 
S C S G T F S Q S F G G Q L Q Y P I S S 
121 TGCGGTTCCTCCTACCCCAACAACGTCTTCTACAGCACTCACCTCCAAACTCCCATCACC 18 0 
C G S S Y P N N V F Y S T D L Q T P I T 
1S1 CACCAGCTGGGCTCTTCTCTTCACAGTGGGTGCCAGGAAACCTTCTGTGAGCCCACCAAC 24 0 
H Q L G S S L H S G C Q E T F C E P T N 
241 TGCCAGACAGCCTATGTGGTCTCCAGACCCTGCCAGAGGCTTTCTACAGTCAGAGGATTC 3C0 
C Q T A Y V V S R P C Q R L S T V R G F 
301 GAGGGCCCTGCAGGCTGCCAGTCAACTTTCTCGGGATCCCTGGGATTTGGTTCCAGGGGT 360 
E G P A G C Q S T F S 
3 61 TTCCAGTCTTTTGGCTGTGGC'IACCGATCCCAGGGCTTTGGATCCCATGGTTTCCAGTCA 4 2 0 
4 21 GTAGGATGTGG7ACCCCTACTTTCTCATCCCTAAATTGTGGATCCAGC1TTTACCGCCCA 4 8 0 
4 81 ACCTGCTTCTCTACCAAAAGCTGCCAGTCTGTTTCTTATCAGCCAACCTGTGGGACTGGC 54 0 
T C F S T K S C Q S V S Y Q P T C G T G 
541 TTCTTCTC-ATC7XTATTGGGGAAAATTAGAAATGTAAAAGGTGCCTACTACCTACTGTGT 600 
F F * 
601 TAAGAGCCGTGCTGTCTTGAGAGTTTCTATATTAGTCTAGAGATTTGACTTCTACTCATG 660 
661 AGTTCCTGTAA?TGGCAAAACGTATTTGATTAGAGAAAGATCCTAAATTGTT7TCTTGTA 720 
721 TATTATAGGTATGCAAAAATCAAGCATAATTCTTTCTTCGCATATCTCTTAGTAATTACT 780 
781 CAGACTGCCGGTCTTGATTTTTGCAAAGAGGAAGGTTGIAAGTTTAflATAflAGATATGCA 840 
841 ACTGGAAAAAAAAAAAAAA 
Fig. 1. Nucleotide sequence and deduced amino acid sequence of 
pmg-l. The amino acid repeat is shaded and the putative poly-
adenylation signal is given in bold and italic. The murine pmg-l 
cDNA sequence has been deposited with GenBank under the acces-
sion number AF003691. 
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Fig. 2. The pmg-l gene is conserved in mammals. Genomic South-
ern blot of DNA from the different mammals indicated digested 
with either BamHl or Hindlll. The positive control consists of the 
linearised full-length pmg-l clone. The probe used for hybridization 
corresponded to full-length pmg-l. Fragment sizes of the Hindlll di-
gested lambda phage DNA are indicated. 
that this cDNA has no homology to any known sequence 
(Fig. 1). We have designated the name pmg-l (pubertal 
mammary gland specific) for this novel gene reflecting its par-
ticular expression pattern (see below), pmg-l has an open 
reading frame encoding a protein with a predicted length of 
166 amino acids (calculated molecular weight 19.9 kDa). The 
start methionine is preceded by a 46 bp 5'-untranslated se-
quence and is flanked by a hexanucleotide conforming to the 
Kozak consensus sequence [18]. The predicted amino acid 
sequence does not contain any known structural motifs which 
would allow a prediction about its function or localization. In 
particular, the lack of a hydrophobic signal peptide and of 
possible N-glycosylation sites suggests that pmg-\ does not 
encode a secreted or membrane-bound protein. An interesting 
feature of the amino acid sequence, however, is an almost 
perfect internal repeat of 17 amino acids at amino acid posi-
tion 97-130. The 3'-untranslated region contains 314 bp and 
terminates with a classical polyadenylation signal. 
Analysis of genomic DNA prepared from a variety of spe-
cies showed that pmg-\ is conserved in mammals including 
humans (Fig. 2). The appearance of multiple bands may re-
flect that pmg-\ constitutes a novel gene family consisting of 
more than one member. Indeed, comparison of the pmg-l 
sequence to the dbEST database [19] identified a cDNA se-
quence from a human fetal heart cDNA library exhibiting 
67% homology in the coding sequence. Furthermore, a mouse 
skin cDNA exhibited 61% homology over 100 bp correspond-
ing to the second 17 amino acid of the observed repeat in 
pmg-l. 
The expression of pmg-l during mammary gland develop-
ment was analyzed by Northern blotting of RNA prepared 
from all the different developmental stages of the mammary 
gland (Fig. 3). pmg-\ detected a single transcript of about 
900 bp corresponding well to the size of the cloned full-length 
cDNA sequence. In the mouse, sexual maturation begins at 
3.5 weeks and between 4 and 6 weeks multi-layered mammary 
epithelial end buds are formed which penetrate into the adi-
pose stroma [1]. pmg-l expression was barely detected in the 
immature gland at 3 weeks but was evident at the onset of 
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Fig. 3. pmg-1 expression during mouse mammary gland development. Poly(A)-enriched RNA prepared from the mammary gland at the devel-
opmental stages indicated was analyzed by Northern blotting. Equal loading was verified by acridine orange staining of the gel (upper panel). 
The probe used for hybridization corresponded to full-length pmg-1. The position of the 18S and 28S rRNA are indicated. The arrow indicates 
the position of pmg-1 RNA. 
puberty at 3.5 weeks. Expression was highly induced at 
4 weeks of age, declined at 4.5 weeks and was undetectable 
at 5 weeks. No expression was detected in mature mammary 
glands during the estrus cycle, pregnancy, lactation and invo-
lution. Beside the pubertal mammary gland, no expression of 
pmg-l was detected in any other organs analyzed (Fig. 4A) 
including the ovaries of pubertal mice (Fig. 4B). These results 
demonstrate that pmg-l expression is restricted to the mam-
mary gland at the onset of pubertal maturation, the time 
point at which end bud formation is induced [20] and high 
cell proliferation is seen in the myoepithelial and epithelial 
cells lining the ducts and in the cells constituting the terminal 
end buds [2]. 
In order to define which cell type in the mammary gland is 
responsible {OT pmg-l expression, we performed in situ hybrid-
ization on mammary glands isolated from 4-week-old females 
using the full-length pmg-l cDNA as a probe (Fig. 5). Hybrid-
ization of the anti-sense probe was clearly localized to the 
epithelial cells of the ducts (Fig. 5B) and more prominently 
to the epithelial cells of the multi-layered alveolar end buds 
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Fig. 4. pmg-1 expression in (A) mouse organs (B) during ovarian development. Poly(A)-enriched RNA prepared from the organs indicated and 
total RNA prepared from ovaries at the indicated developmental stages was analyzed by Northern blotting using full-length pmg-l as the 
probe. The position of the 18S and 28S rRNA are indicated. The arrow indicates the expected position of pmg-1 RNA. 
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Fig. 5. In situ hybridization of pmg-1 in the pubertal mammary gland. A,C: Sense probe; B,D: antisense probe. Panels A and B illustrate a 
mammary gland duct and panels C and D represent a cross-section through multi-layered mammary epithelium of a mammary gland from a 
pubertal 4.5-week-old female. Magnification: X250 (A,B); X300 (C,D). 
(Fig. 5D). No signal was seen in the fibroblasts surrounding 
the epithelial structures, in the adipose stroma or after hybrid-
ization with the control sense probe (Fig. 5A,C). Interestingly, 
not all epithelial cells hybridized to the same extent and occa-
sionally pmg-l positive cells were seen adjacent to non-ex-
pressing cells. This may be due to asynchronous expression 
of pmg-l in the mammary epithelial cells. Alternatively, the 
differential expression of pmg-l could also reflect the different 
epithelial cell populations present in the mammary ductal tree. 
The pubertal terminal end buds are thought to originate from 
pluripotent stem cells which are interspersed in the determined 
ductal epithelial cells [20]. It remains to be investigated if these 
pluripotent stem cells are indeed those expressing pmg-l. The 
number of pubertal end buds, consisting of undifferentiated 
mitotically active cells, has been positively correlated with the 
development of mammary cancer [21] and thus a potential 
role of pmg-l in mammary carcinogenesis has to be consid-
ered. 
In summary, our results document the first isolation of a 
gene whose expression is exquisitely specific for the onset of 
the branching morphogenesis of the mammary epithelium at 
puberty. This phase is governed mainly by estrogen, growth 
hormone and insulin-like growth factor-1, TGF-oc and here-
gulin-oc [22,23]. The responsiveness to progesterone is only 
acquired later around 7 weeks [24]. It will be important to 
elucidate, which hormones required for the induction of mam-
mary gland maturation are inducing the expression of pmg-l. 
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